Presentient develops a platform that analyzes blinded clinical trial data in real-time to predict outcomes with high accuracy, significantly reducing trial durations from years to months. This capability enables pharmaceutical companies to save billions by accelerating the drug development process.
Funding
Funding not disclosed
QFounders
Product
Problem
Traditional clinical trials often take years to complete, incurring significant costs for pharmaceutical companies and delaying the availability of potentially life-saving drugs. The lengthy duration is due to the time required to collect and analyze data, often revealing critical insights only at the trial's conclusion.
Solution
Presentient offers a platform designed to analyze blinded clinical trial data in real-time, enabling pharmaceutical companies to predict trial outcomes with greater accuracy and speed. By providing continuous insights into trial progress, the platform aims to significantly reduce trial durations from years to months. This accelerated timeline allows for faster decision-making, potentially saving billions in development costs and expediting the delivery of new therapies to patients.
Target Audience
The primary target audience includes pharmaceutical companies and clinical research organizations seeking to accelerate drug development timelines and reduce associated costs.
Features
- Real-time analysis of blinded clinical trial data
- Predictive modeling for accurate outcome forecasting
- Identification of trends and patterns during the trial
- Customizable dashboards for data visualization
- Secure data storage and access controls